As a clinician I witnessed first-hand the transformative effects of immunotherapy on difficult to treat cancers, achieving the possibility of a "cure" for metastatic cancer. This inspired me to go into research to understand immune- tumour interactions further and test new immune-based therapies.
I hope that this will impact cancer patients by providing new treatments to patients who would not have had access to immunotherapy as well as expanding the use of oncolytic viruses which are an exciting treatment modality.